RecruitingNCT02647879
Treatment as Prevention for Hepatitis C in Iceland
Treatment as Prevention for Hepatitis C in Iceland. A Nationwide Campaign for Reducing Disease Burden Using Combination Antiviral Treatment
Sponsor
Landspitali University Hospital
Enrollment
1,000 participants
Start Date
Jan 1, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
The main aim of this study is to test in the Icelandic population the hypothesis that a nationwide treatment program which offers effective treatment to all known cases of Hepatitis C with the aim of halting HCV (Hepatitis C virus) transmission will lead to a reduction in incidence and disease burden associated with chronic HCV infection.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- HCV positive subjects 18 years and older, living in Iceland and covered by the Icelandic Health Insurance.
Exclusion Criteria2
- Age under 18 years
- Inability to sign informed consent.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02647879
Related Trials
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
NCT012808251 location
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
NCT0539042411 locations
The Hepatitis C Transplant Collaborative
NCT044933851 location
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
NCT0703727789 locations
Evaluation of Patients With Liver Disease
NCT000019711 location